上海美迪西生物医药股份有限公司股东减持计划时间届满暨减持股份结果公告

Core Viewpoint - The announcement details the completion of a share reduction plan by a major shareholder of Shanghai Medicilon Inc, highlighting the amount of shares reduced and the shareholder's motivations for the reduction [1][2]. Shareholder Holdings - Prior to the reduction plan, shareholder Lin Changqing held 5,473,654 shares, accounting for 4.07% of the total share capital of the company. Together with his concerted actor Chen Guoxing, they held a total of 10,348,808 shares, representing 7.70% of the total share capital [1]. Reduction Plan Implementation Results - On July 19, 2025, the company disclosed a share reduction plan, where Lin Changqing intended to reduce his holdings by up to 2,000,000 shares, or 1.49% of the total share capital, due to personal funding needs. The reduction was to be executed within three months following the disclosure [2]. - As of November 10, 2025, Lin Changqing had successfully reduced his holdings by 1,542,484 shares, which is 1.15% of the total share capital, thus fulfilling the reduction plan [2][4]. - The reduction plan was completed within the specified timeframe, and the actual reduction met the planned minimum reduction quantity [3][4].